Celularity Inc. Common Stock, Value, Issued
Celularity Inc. (CELU) had Common Stock, Value, Issued of $3.00 thousand as of 2025-12-31, per its 10-K filed 2026-04-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-04-30
- 2025-12-31: Common Stock, Value, Issued $3.00K.
- 2025-09-30: Common Stock, Value, Issued $3.00K.
- 2025-06-30: Common Stock, Value, Issued $2.00K.
- 2025-03-31: Common Stock, Value, Issued $2.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2025-12-31 | $3.00K 10-K · filed 2026-04-30 | |
| 2025-09-30 | $3.00K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.00K 10-Q · filed 2025-08-29 | |
| 2025-03-31 | $2.00K 10-Q · filed 2025-08-29 | |
| 2024-12-31 | $2.00K 10-K · filed 2026-04-30 | |
| 2024-09-30 | $2.00K 10-Q · filed 2024-12-06 | |
| 2024-06-30 | $2.00K 10-Q · filed 2024-11-07 | |
| 2024-03-31 | $2.00K 10-Q · filed 2024-10-16 | |
| 2023-12-31 | $19.00K 10-K · filed 2025-05-08 | |
| 2023-09-30 | $19.00K 10-Q · filed 2024-01-03 | |
| 2023-06-30 | $18.00K 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $17.00K 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $15.00K 10-K · filed 2024-07-30 | |
| 2022-09-30 | $14.00K 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $14.00K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $14.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $12.00K 10-K · filed 2023-03-31 | |
| 2021-09-30 | $10.00K 10-Q · filed 2021-11-12 | |
| 2020-12-31 | $1.00K 10-K · filed 2022-03-31 | $815.00 10-K/A · filed 2021-05-24 |
| 2020-09-30 | $151.00 10-Q · filed 2020-11-16 | |
| 2019-12-31 | $317.00 10-K/A · filed 2021-05-24 | $147.00 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |